Abstract
Plastic-adherent depleted or not depleted peripheral mononuclear blood cells (PMBC) from healthy donors showed enhanced lytic activity against51Cr-labelled K562 target cells when exposed to thymostimulin (TS), 1 μg ml-1, for 3 h, washed and incubated in TS-free medium before testing for natural killer (NK) cytotoxicity. No modification of NK cell activity was seen when effector cells were treated with placebo (splenic extract). The NK boosting activity of TS was lost when effector cells were treated for 3 h immediately before the performance of the cytotoxic test or when this thymic extract was added directly to the mixture of effector and target cells during the lytic phase of51Cr release assay.
Similar content being viewed by others
References
Schulof R S: Thymic peptide hormones: basic properties and clinical applications in cancer.CRC Crit Rev Oncol Hemat 3, 309 (1985).
Lau C Y, Wang E Y, Goldstein G: Studies of thymopoietin pentapeptides (TP5) on experimental tumors. TP5 relieves immunosuppression in tumorbearing mice.Cell Immun 66, 217 (1982).
Takeichi N, Koga Y, Fujii T, Kobayashi H: Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.Cancer Res 45, 487 (1985).
Zatz M M, Glaser M, Seals C M, Goldstein A L: Effects of combined cyclophosphamide and thymosin treatment on tumor growth and host survival in mice bearing a syngeneic tumor, in Goldstein A L, Chirigos M A (eds):Cancer Therapeutics, p. 249. New York, Raven Press (1981).
Tovo P A, Bernengo M G, Cordero di Montezemolo L, Del Piano A, Saitta M, Nicola P: Thymus extract therapy in immunodepressed patients with malignancies and herpes virus infections.Thymus 2, 41 (1980).
Haneke E, Bolla K, Degreef H, Djawari D, Demaubeuge J, Molin L, Panconesi E, Schöpf E, Stengel R, Stingl G, Wolff K, Wüthrich B: The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.Int J clin pharm Res 4, 439 (1984).
Martelli M F, Velardi A, Rambotti P, Cernetti C, Bertotto A, Spinozzi F, Bracaglia A M, Falini B, Davis S: Thein vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin’s disease.Cancer 50, 490 (1982).
Thurman G B, Seals C, Low T L K, Goldstein A L: Restorative effects of thymosin polypeptides on purified protein derivative dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigs.J biol Resp Mod 3, 160 (1984).
Neta R, Salvin S B: Resistance and susceptibility to infection in inbred murine strains. II. Variations in the effect of treatment with thymosin fraction 5 on the release of lymphokinesin vivo.Cell Immun 75, 173 (1983).
Ohta Y, Tamura S, Nihira S, Tezuka E, Imai S, Yagi Y: Thymosin α1 enhances haemopoietic colony formation by stimulating the production of interleukin 3 innu/nu mice.Int J Immunopharmac 8, 773 (1986).
Ohta Y, Tezuka E, Tamura S, Sugawara M, Nihira S, Imai S, Yagi Y: Thymosin-α increases the capability to produce interleukin-3 but not interleukin-2 innu/ nu mice.J biol Resp Mod 6, 181 (1987).
Zatz M M, Oliver J, Samuels C, Skotnicki A B, Sztein M B, Goldstein A L: Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.Proc natn Acad Sci USA 81, 2882 (1984).
Zatz M M, Oliver J, Sztein M B, Skotnicki A B, Goldstein A L: Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production.J biol Resp Mod 4, 365 (1985).
Liberati A M, Ballatori E, Fizzotti M, Schippa M, Cini L, Cinieri S, Proietti M G, Di Marzio R, Senatore M, Grignani F: A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin’s disease in complete remission.Cancer Immun Immunother 26, 87 (1988).
Palacios R: Role of serum thymic factor (FTS) in the development of interleukin-2 producer lymphocytes.Clin Immun Allergy 3, 83 (1983).
Grinblat J, Schauenstein K, Saltz E, Trainin N, Globerson A: Regulatory effects of thymus humoral factor on T cell growth factor in aging mice.Mech Ageing Devel 22, 209 (1983).
Katorza E, Pecht M, Apte R N, Benharroch D, Burstein Y, Trainin N, Rager-Zisman B: Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).Clin exp Immun 70, 268 (1987).
Zatz M M, Goldstein A L: Mechanism of action of thymosin. I. Thymosin fraction 5 increases lymphokine production by mature murine T cells responcling in a mixed lymphocyte reaction.J Immun 134, 1032 (1985).
Shoham J, Eshel I, Aboud M, Salzberg S: Thymic hormonal activity on human peripheral blood lymphocytesin vitro — II. Enhancement of the production of immune interferon by activated cells.J Immun 125, 54 (1980).
Svedersky L P, Hui A, May L, McKay P, Stebbing N: Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by Nα-desacetylthymosin α1 Eur J Immun 12, 244 (1982).
Huang K Y, Kind P D, Jagoda E J, Goldstein A L: Thymosin treatment modulates production of interferon.J Interfer Res 1, 411 (1981).
Henney C S, Kuribayashi K, Kern D E, Gillis S: Interleukin-2 augments natural killer cell activity.Nature 291, 335 (1981).
Kuribayashi K, Gillis S, Kern D E, Henney C: Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.J Immun 126, 2321 (1981).
Umeda Y, Sakamoto A, Nakamura J, Ishitsuka H, Yagi Y: Thymosin α1 restores NK cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.Cancer Immun Immunother 15, 78 (1983).
Favalli C, Jezzi T, Mastino A, Rinaldi-Garaci C, Riccardi C, Garaci E: Modulation of natural killer activity by thymosin alpha 1 and interferon.Cancer Immun Immunother 20, 189 (1985).
Bistoni F, Baccarini M, Pucetti P, Marconi P, Garaci E: Enhancement of natural killer cell activity in mice by treatment with a thymic factor.Cancer Immun Immunother 17, 51 (1984).
Serrate S, Schulof R S, Leondaridis L, Goldstein A L, Sztein M B: Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.J Immun 139, 2338 (1987).
Liberati A M, Brugia M, Edwards B S, Bertoni P, Ballatori E, Puxeddu A, Grignani F: Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin’s disease in clinical remission.Cancer Immun Immunother 19, 136 (1985).
Fiorilli M, Sirianni M C, Pandolfi F, Quinti I, Tosti U, Aiuti F, Goldstein G: Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.Clin exp Immun 45, 344 (1981).
Bordigoni P, Bienie M C, Faure G, Donner M, Janot C, Dardenne M, Duheille J, Oliver D: Allogeneic bone marrow transplantation in man:in vitro activity of FTS-Zn on T-cell markers and functions.Br J Haemal 58, 661 (1984).
Dokhelar M C, Tursz T, Dardenne M, Bach J F: Effect of synthetic thymic factor (facteur thymique serique) on natural killer cell activity in humans.Int J Immunopharmac 5, 277 (1983).
Bardos P, Bach J F: Modulation of mouse natural killer cell activity by the serum thymic factor.Scand J Immun 15, 321 (1982).
Kaiserlian D, Savino W, Dardenne M: Studies of the thymus in mice bearing the Lewis lung carcinoma — II. Modulation of thymic natural killer activity by thymulin (FTS-Zn) and the antimetastatic effect of zinc.Clin Immun Immunopath 28, 192 (1983).
Kaiserlian D, Bardos P, Bach J F:In vitro modulation of mouse natural killer (NK) cell activity by the serum thymic factor (FTS).Cell Immun 76, 232 (1983).
Falchetti R, Bergesi G, Eshkol A, Cafiero C, Adorini L, Caprino L: Pharmacological and biological properties of a calf thymus extract (TP-1).Drugs exp clin Res 3, 39 (1977).
Bergesi G, Falchetti R: Caratterizzazione chimica ed attività biologica di un nuovo estratto timico.Fol Allerg Immun Clin 24, 204 (1977).
Liberati M, Borden E C, McBain J A, Raubertas R: Effects of levamisole on human natural killer and killer cell activity and production of interferons.Immunopharmacology 5, 11 (1982).
Hanna M:In vivo activities of NK cells against primary and metastatic tumors in experimental animals, in Lotzova E, Herberman R B (eds):Immunobiology of Natural Killer Cells, pp. 1–10. Boca Raton, FL, CRC Press (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liberati, A.M., Cinieri, S., Fizzotti, M. et al. Modulation of NK activity by thymic hormones:in vitro effects of thymostimulin. Med. Oncol. & Tumor Pharmacother. 6, 45–52 (1989). https://doi.org/10.1007/BF02985222
Issue Date:
DOI: https://doi.org/10.1007/BF02985222